首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
GUSSASPHALTEINBAUGERAET
摘要
申请公布号
DE1658532(B2)
申请公布日期
1976.11.18
申请号
DE196701S1067
申请日期
1967.07.28
申请人
发明人
分类号
E01C19/21;E01C19/42;(IPC1-7):E01C19/48
主分类号
E01C19/21
代理机构
代理人
主权项
地址
您可能感兴趣的专利
PRODUCT WITH A MARK SUITABLE FOR AN INDIVIDUAL IDENTIFICATION AND A METHOD FOR PRODUCING SAID PRODUCT
LIMRBO1 VARIETY OF INBRED CORN LINE (ZEA MAYS L.)
2X7511 VARIETY OF INBRED CORN LINE (ZEA MAYS L.)
PIPE SECTION COMPRISING AN ANNULAR INSULATION LAYER AND A METHOD FOR ITS PRODUCTION
CAMAROSA VARIETY OF STRAWBERRY (FRAGARIA L.)
RHA-NS-W-1 VARIETY OF INBRED SUNFLOWER LINE (HELIANTHUS ANNUUS L.)
BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NOVEL MORPHOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
QUINAZOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, AND PROCESSES FOR PREPARING THEM
PROCESS FOR PRODUCING FINE POWDERED CAOUTCHOUC
AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
SUBSTITUTED INDOLES AS ANGIOTENSIN II ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, PROCESS FOR THEIR PRODUCTION AND INTERMEDIATES
A PROCESS FOR MAKING N-(4-FLUOROPHENYL)-N-(1-METHYLETHYL)-2-[5-TRIFLUOROMETHYL)-1,3,4-THIADIAZOL-2-YL]OXY-ACETAMIDE USING AN APROTIC AROMATIC SOLVENT
MODIFIED CILIARY NEUROTROPHIC FACTOR, METHOD OF MAKING AND METHODS OF USE THEREOF
INTERLEUKIN-5 SPECIFIC RECOMBINANT ANTIBODIES
METHODS AND DEVICES FOR CREATING LIST OF THE SIGNAL DISPLACEMENTS FROM SEVERAL TRANSMITTER UNIT, AS WELL AS, RADIO POSITIONING METHOD AND SYSTEM, AND DIGITAL TELEPHONE NETWORK
FORNULATIONS FOR PARENTERAL USE OF ESTRAMUSTINE PHOSPHATE AND ALBUMIN
TREATMENT OF MIGRAINE BY USING ALPHA-LIPOIC ACID OR DERIVATIVES THEREOF
METAL CUP CONSTRUCTION FOR FIREING SOLUTION CONTAINING FLAME COLORANT METAL SALTS
IMMUNOLOGICAL PROCESS FOR DETECTING ANTIBODIES DIRECTED TOWARDS TISSUE TRANSGLUTAMINASE (TTG), USE OF TTG FOR DIAGNOSTIC PURPOSES AND THERAPY CONTROL, AND ORAL PHARMACEUTICAL AGENT CONTAINING TTG
